Trial Profile
A follow-up study investigating the efficacy of adalimumab against anterior uveitis in patients in ankylosing spondylitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Anterior uveitis
- Focus Therapeutic Use
- 06 Dec 2015 New trial record